Anti-bodies that fight Ebola viruses are now a reality

August 1, 2018

Finally, anti-bodies to three major Ebola viruses have now been developed. Researchers at Vanderbilt University Medical Center are a step closer to developing a broadly effective antibody treatment against these viruses that cause the lethal disease in humans. Researchers found that the isolation of two potent monoclonal antibodies from human survivors of Ebola virus disease in cell culture studies efficiently neutralized the Zaire, Sudan and Bundibugyo Ebola viruses.

Ebola Antibodies Show Protection Potential in Animal Studies

July 23, 2018

Two types of antibodies from the blood of Ebola survivors protected animals against strains of the virus that cause deadly infections in people, researchers report. It may be possible to use these antibodies to create a treatment for Ebola, the researchers said.

Crowe Lab Wins Best Academic Research Award

April 10, 2018

The laboratory of James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week. The congress is an annual meeting of vaccine professionals from industry, academia and nonprofit organizations. The awards are given to recognize outstanding achievements by companies, research teams and individuals in the vaccine industry.